CoChat

Activatin’ human adipose progenitors in obesity

Open access
Sethi, Jaswinder K. · 2010 · Diabetes

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Obesity relates to the abnormal accumulation of body fat and is associated with a number of morbidities including diabetes, dyslipidemia, cardiovascular disease, and cancer. Great strides have been made in our understanding of the molecular basis for these associations, and a number of hypotheses have been put forward. One seemingly counterintuitive hypothesis is the “adipose tissue expandability hypothesis,” which suggests that the relative accumulation of adipose mass per se may not be directly causative in obesity-related metabolic abnormalities; instead, adipose tissue function and plasticity are the key determinants. Although adipose tissue is arguably the most plastic organ in our bodies, it cannot expand indefinitely—particularly in the face of years of chronic fuel surplus. Furthermore, when such a limit is reached, this would inevitably set a limit on the body's capacity to safely store neutral triglycerides. Consequently, with continued nutritional overload, excess fat is deposited in ectopic sites, in tissues not specialized to store large amounts of triglycerides. The result is lipotoxicity and metabolic dysregulation of peripheral tissues (1). Similar metabolic consequences may also be predicted when one considers impaired adipose tissue function (dysregulated adipose metabolism and endocrinology) or indeed when there is a paucity of adipose tissue. Recent evidence points to substantial adipose tissue remodeling, particularly in cases associated with metabolic dysregulation. Obese dysfunctional adipose tissue is characterized by adipocyte hypertrophy, increased angiogenesis, immune infiltration, increased extracellular matrix deposition/fibrosis, and chronic inflammation. In contrast, growth of healthy adipose tissue mass is determined by a complex coordination of adipocyte hypertrophy, adipocyte hyperplasia, adipocyte death, and angiogenesis. Furthermore, all these events appear to be orchestrated in a cell-type, context-dependent, and temporal manner. Indeed, in weight stable individuals, adipocyte turnover is thought to be balanced by the acquisition of new adipocytes from adult adipose tissue progenitors (mesenchymal stem cells and preadipocytes) via adipogenesis …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db10-0923

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Activin A–mediated signal transduction promotes cell proliferation and inhibits adipogenesis. Activin receptor specificities and intracellular signal transducers appear complex and incompletely delineated, in part because activin A receptors can also transduce signals of other TGF-β superfamily members. They may also be tissue- and context-specific. Nonetheless, activin A has been reported to bind both type IIA (activin receptor type-2A; ActRIIA or ACVR2A) and type IIB (activin receptor type-2B; ActRIIB or ACVR2B) surface receptors. This receptor-ligand interaction leads to the recruitment, transphosphorylation, and activation of the type I activin receptor (ACVR1B or ALK-4). The receptor then interacts with and phosphorylates cytoplasmic SMAD2, which multimerizes with SMAD4 and translocates to the nucleus where these proteins can act as transcription factor complexes to induce a subset of genes implicated in stem cell renewal or differentiation. SMAD2 is required to promote activin A–induced cell proliferation and to suppress adipogeic expression of C/EBPβ.
FIG. 1. Activin A–mediated signal transduction promotes cell proliferation and inhibits adipogenesis. Activin receptor specificities and intracellular signal transducers appear complex and incompletely delineated, in part because activin A receptors can also transduce signals of other TGF-β superfamily members. They may also be tissue- and context-specific. Nonetheless, activin A has been reported to bind both type IIA (activin receptor type-2A; ActRIIA or ACVR2A) and type IIB (activin receptor type-2B; ActRIIB or ACVR2B) surface receptors. This receptor-ligand interaction leads to the recruitment, transphosphorylation, and activation of the type I activin receptor (ACVR1B or ALK-4). The receptor then interacts with and phosphorylates cytoplasmic SMAD2, which multimerizes with SMAD4 and translocates to the nucleus where these proteins can act as transcription factor complexes to induce a subset of genes implicated in stem cell renewal or differentiation. SMAD2 is required to promote activin A–induced cell proliferation and to suppress adipogeic expression of C/EBPβ.CC BY-NC-ND · PubMed Central
FIG. 2. Local autocrine and paracrine signals regulate progenitor proliferation and titrate adipogenesis. Remarkable parallels are emerging between the Wnt/β-catenin signaling network (A) and the activin signaling network (B). These suggest that maturing adipocytes may produce proadipogenic signals that inhibit progenitor proliferation and promote preadipocyte recruitment.
FIG. 2. Local autocrine and paracrine signals regulate progenitor proliferation and titrate adipogenesis. Remarkable parallels are emerging between the Wnt/β-catenin signaling network (A) and the activin signaling network (B). These suggest that maturing adipocytes may produce proadipogenic signals that inhibit progenitor proliferation and promote preadipocyte recruitment.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 28

Metadata

Authors
Sethi, J. K.
Affiliations
University of Cambridge (GB)
Corresponding author
Sethi, Jaswinder K.
Venue
Diabetes
Published
2010-10-01
Volume
59
Issue
10
Pages
2354-2357
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2143367838
Cited by
25
References
20
Citations by year
2026: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2019: 2 · 2018: 1 · 2016: 4 · 2015: 2 · 2014: 5 · 2013: 2 · 2012: 2
FWCI
0.93
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
Funders
  • British Heart Foundation (PG/10/38/28359)
  • Biotechnology and Biological Sciences Research Council (JF16994)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
obesity, adipose tissue plasticity, adipose tissue remodeling, adipocyte hypertrophy, adipocyte hyperplasia, adipocyte turnover, mesenchymal stem cells, preadipocytes, adipogenesis, ectopic fat deposition, lipotoxicity, angiogenesis
MeSH terms
Adipose Tissue, Cell Division, Humans, Obesity, Signal Transduction, Adipocytes, Neovascularization, Physiologic, Inhibin-beta Subunits, Activins, Adipogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.